Advertisement
Screener

MORGAN STANLEY (MS) Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net

2.8 / 5 stars · 45/80 Roast Me

MORGAN STANLEY Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net

MORGAN STANLEY (MS) reported Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net of -$186.00 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-02.

Discontinued › Income Statement › Other Income

us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet · last filed 2015-03-02

  • MORGAN STANLEY derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for the quarter ending 2014-12-31 was -$43.00M.
  • MORGAN STANLEY derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for the quarter ending 2014-09-30 was -$46.00M.
  • MORGAN STANLEY derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for the quarter ending 2014-06-30 was -$52.00M, a 244.44% decline year-over-year.
  • MORGAN STANLEY derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for the quarter ending 2014-03-31 was -$45.00M.
  • MORGAN STANLEY derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for fiscal 2014 was -$186.00M.
  • MORGAN STANLEY derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for fiscal 2013 was -$154.00M.
  • MORGAN STANLEY derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for fiscal 2012 was -$235.00M.
  • MORGAN STANLEY derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for fiscal 2011 was -$220.00M.
Period endDerivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 3 monthDerivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 3 month as first filedDerivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 6 monthDerivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 6 month as first filedDerivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 9 monthDerivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 9 month as first filedDerivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 12 month
2014-12-31-$43.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02
-$89.00M
derived: sum of 2 quarters · filed 2015-03-02
-$141.00M
derived: sum of 3 quarters · filed 2015-03-02
-$186.00M
10-K · filed 2015-03-02
2014-09-30-$46.00M
10-Q · filed 2014-11-04
-$98.00M
derived: sum of 2 quarters · filed 2014-11-04
-$143.00M
10-Q · filed 2014-11-04
-$194.00M
derived: sum of 4 quarters · filed 2015-03-02
2014-06-30-$52.00M
10-Q · filed 2014-08-05
-$97.00M
10-Q · filed 2014-08-05
-$148.00M
derived: sum of 3 quarters · filed 2015-03-02
-$182.00M
derived: sum of 4 quarters · filed 2015-03-02
2014-03-31-$45.00M
10-Q · filed 2014-05-06
-$96.00M
derived: sum of 2 quarters · filed 2015-03-02
-$130.00M
derived: sum of 3 quarters · filed 2015-03-02
-$94.00M
derived: sum of 4 quarters · filed 2015-03-02
2013-12-31-$51.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02
-$85.00M
derived: sum of 2 quarters · filed 2015-03-02
-$49.00M
derived: sum of 3 quarters · filed 2015-03-02
-$154.00M
10-K · filed 2015-03-02
2013-09-30-$34.00M
10-Q · filed 2014-11-04
$2.00M
derived: sum of 2 quarters · filed 2014-11-04
-$103.00M
10-Q · filed 2014-11-04
-$72.00M
derived: sum of 4 quarters · filed 2015-03-02
2013-06-30$36.00M
10-Q · filed 2014-08-05
-$36.00M
10-Q · filed 2013-08-02
$68.00M
10-Q · filed 2014-08-05
-$68.00M
10-Q · filed 2013-08-02
-$38.00M
derived: sum of 3 quarters · filed 2015-03-02
-$103.00M
derived: sum of 4 quarters · filed 2015-03-02
2013-03-31-$32.00M
10-Q · filed 2014-05-06
-$74.00M
derived: sum of 2 quarters · filed 2015-03-02
-$139.00M
derived: sum of 3 quarters · filed 2015-03-02
-$202.00M
derived: sum of 4 quarters · filed 2015-03-02
2012-12-31-$42.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02
-$107.00M
derived: sum of 2 quarters · filed 2015-03-02
-$170.00M
derived: sum of 3 quarters · filed 2015-03-02
-$235.00M
10-K · filed 2015-03-02
2012-09-30-$65.00M
10-Q · filed 2013-11-04
-$128.00M
derived: sum of 2 quarters · filed 2013-11-04
-$193.00M
10-Q · filed 2013-11-04
-$238.00M
derived: sum of 4 quarters · filed 2014-02-25
2012-06-30-$63.00M
10-Q · filed 2013-08-02
-$128.00M
10-Q · filed 2013-08-02
-$173.00M
derived: sum of 3 quarters · filed 2014-02-25
-$240.00M
derived: sum of 4 quarters · filed 2014-02-25
2012-03-31-$66.00M
10-Q · filed 2013-05-07
-$110.00M
derived: sum of 2 quarters · filed 2014-02-25
-$177.00M
derived: sum of 3 quarters · filed 2014-02-25
-$239.00M
derived: sum of 4 quarters · filed 2014-02-25
2011-12-31-$44.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25
-$111.00M
derived: sum of 2 quarters · filed 2014-02-25
-$173.00M
derived: sum of 3 quarters · filed 2014-02-25
-$220.00M
10-K · filed 2014-02-25
2011-09-30-$67.00M
10-Q · filed 2012-11-06
$67.00M
10-Q · filed 2011-11-07
-$129.00M
derived: sum of 2 quarters · filed 2012-11-06
-$176.00M
10-Q · filed 2012-11-06
$176.00M
10-Q · filed 2011-11-07
-$426.00M
derived: sum of 4 quarters · filed 2013-02-26
2011-06-30-$62.00M
10-Q · filed 2012-08-06
-$109.00M
10-Q · filed 2012-08-06
-$359.00M
derived: sum of 3 quarters · filed 2013-02-26
-$326.00M
derived: sum of 4 quarters · filed 2013-02-26
2011-03-31-$47.00M
10-Q · filed 2012-05-07
-$297.00M
derived: sum of 2 quarters · filed 2013-02-26
-$264.00M
derived: sum of 3 quarters · filed 2013-02-26
2010-12-31-$250.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26
-$217.00M
derived: sum of 2 quarters · filed 2013-02-26
-$147.00M
10-K · filed 2013-02-26
2010-09-30$33.00M
10-Q · filed 2011-11-07
$103.00M
10-Q · filed 2011-11-07
2009-12-31-$151.00M
10-K · filed 2012-02-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
SCHWAB CHARLES CORP (SCHW)United States$172.086B15.89
BlackRock, Inc. (BLK)United States$166.261B22.64
RAYMOND JAMES FINANCIAL INC (RJF)United States$30.545B12.66
SEI INVESTMENTS CO (SEIC)United States$12.579B14.88
Freedom Holding Corp. (FRHC)$11.250B51.95
Jefferies Financial Group Inc. (JEF)United States$9.447B12.42
MARKETAXESS HOLDINGS INC (MKTX)United States$5.764B13.05
PIPER SANDLER COMPANIES (PIPR)United States$5.018B15.90
STIFEL FINANCIAL CORP (SF)United States$4.865B4.11
Interactive Brokers Group, Inc. (IBKR)United States$3.794B0.75